iRadimed Corporation (IRMD): Price and Financial Metrics

iRadimed Corporation (IRMD): $33.69

-0.07 (-0.21%)

POWR Rating

Component Grades














  • IRMD scores best on the Sentiment dimension, with a Sentiment rank ahead of 99.89% of US stocks.
  • The strongest trend for IRMD is in Momentum, which has been heading down over the past 48 weeks.
  • IRMD's current lowest rank is in the Momentum metric (where it is better than 15.56% of US stocks).

IRMD Stock Summary

  • IRMD's current price/earnings ratio is 91.02, which is higher than 91.43% of US stocks with positive earnings.
  • Price to trailing twelve month operating cash flow for IRMD is currently 49.84, higher than 90.83% of US stocks with positive operating cash flow.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.16 for Iradimed Corp; that's greater than it is for just 10.23% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Iradimed Corp, a group of peers worth examining would be CXDO, EVER, UCTT, SPNE, and HAPP.
  • Visit IRMD's SEC page to see the company's official filings. To visit the company's web site, go to

IRMD Valuation Summary

  • In comparison to the median Healthcare stock, IRMD's price/sales ratio is 3.96% higher, now standing at 11.8.
  • IRMD's price/earnings ratio has moved up 46.9 over the prior 87 months.
  • Over the past 87 months, IRMD's price/earnings ratio has gone up 46.9.

Below are key valuation metrics over time for IRMD.

Stock Date P/S P/B P/E EV/EBIT
IRMD 2021-08-31 11.8 6.4 91.0 71.4
IRMD 2021-08-30 11.7 6.4 90.5 71.0
IRMD 2021-08-27 11.8 6.4 90.9 71.4
IRMD 2021-08-26 11.7 6.4 90.3 70.8
IRMD 2021-08-25 11.6 6.3 89.2 69.8
IRMD 2021-08-24 11.7 6.4 90.4 70.9

IRMD Growth Metrics

  • Its 4 year revenue growth rate is now at 15.46%.
  • Its year over year net cashflow from operations growth rate is now at -48.31%.
  • Its 5 year price growth rate is now at -37.21%.
IRMD's revenue has moved down $3,477,531 over the prior 15 months.

The table below shows IRMD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 35.27956 8.344037 4.568603
2021-03-31 32.26383 5.563942 0.986639
2020-12-31 31.71737 5.817496 1.369001
2020-09-30 34.06198 7.270287 3.97327
2020-06-30 36.32619 9.074332 5.353494
2020-03-31 38.75709 10.76416 9.554605

IRMD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • IRMD has a Quality Grade of A, ranking ahead of 96.99% of graded US stocks.
  • IRMD's asset turnover comes in at 0.488 -- ranking 96th of 182 Medical Equipment stocks.
  • NUVA, ELMD, and XENT are the stocks whose asset turnover ratios are most correlated with IRMD.

The table below shows IRMD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.488 0.753 0.283
2021-03-31 0.457 0.749 0.017
2020-12-31 0.455 0.743 -0.031
2020-09-30 0.497 0.742 0.053
2020-06-30 0.545 0.753 0.144
2020-03-31 0.609 0.768 0.401

IRMD Price Target

For more insight on analysts targets of IRMD, see our IRMD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $38.00 Average Broker Recommendation 1.25 (Strong Buy)

IRMD Stock Price Chart Interactive Chart >

Price chart for IRMD

IRMD Price/Volume Stats

Current price $33.69 52-week high $40.51
Prev. close $33.76 52-week low $20.52
Day low $32.91 Volume 82,000
Day high $33.91 Avg. volume 28,935
50-day MA $34.39 Dividend yield N/A
200-day MA $28.04 Market Cap 414.99M

iRadimed Corporation (IRMD) Company Bio

IRadimed Corporation manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible products in the United States and internationally. The company was founded in 1992 and is based in Winter Springs, Florida.

IRMD Latest News Stream

Event/Time News Detail
Loading, please wait...

IRMD Latest Social Stream

Loading social stream, please wait...

View Full IRMD Social Stream

Latest IRMD News From Around the Web

Below are the latest news stories about Iradimed Corp that investors may wish to consider to help them evaluate IRMD as an investment opportunity.

IRadimed Corporation's (NASDAQ:IRMD) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

IRadimed's (NASDAQ:IRMD) stock is up by a considerable 19% over the past three months. However, we decided to pay...

Yahoo | August 2, 2021

IRADIMED CORPORATION Announces Second Quarter 2021 Financial Results

Reports second quarter 2021 revenue of $9.8 million, GAAP diluted EPS of $0.12 and non-GAAP diluted EPS of $0.14Issues Q3 and full year 2021 financial guidance WINTER SPRINGS, Fla., July 30, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system, and non-magnetic patient vital signs monitoring sys

Yahoo | July 30, 2021

Products in Magnetic Resonance Imaging (MRI) Systems Markets Are Used To Diagnose and Monitor Almost Every Type of Disease

Launch of MRI compatible monitoring systems is expected to propel growth of the magnetic resonance imaging (MRI) systems market. In December 2019, Iradimed Corporation announced completion of the CE Mark renewal process for its MRI compatible patient vital signs monitoring

OpenPR | July 28, 2021

IRadimed (IRMD) Earnings Expected to Grow: Should You Buy?

IRadimed (IRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 23, 2021

iRadimed (IRMD) Stock Jumps 11.3%: Will It Continue to Soar?

iRadimed (IRMD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Yahoo | July 14, 2021

Read More 'IRMD' Stories Here

IRMD Price Returns

1-mo 1.78%
3-mo 18.42%
6-mo 43.00%
1-year 60.28%
3-year -3.47%
5-year 94.85%
YTD 47.76%
2020 -2.48%
2019 -4.42%
2018 61.45%
2017 36.49%
2016 -60.40%

Continue Researching IRMD

Want to see what other sources are saying about Iradimed Corp's financials and stock price? Try the links below:

Iradimed Corp (IRMD) Stock Price | Nasdaq
Iradimed Corp (IRMD) Stock Quote, History and News - Yahoo Finance
Iradimed Corp (IRMD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.1017 seconds.